Heptares Co-Founder Resigns as VP and CSO of Parent Company Sosei Post author:Sam Post published:January 18, 2018 Post category:BioPharma Dr. Marshall will leave Sosei at the end of February 2018. Source: BioSpace You Might Also Like These 3 Big Biotechs Could Have New Blockbuster Drugs Very Soon April 9, 2017 Mitsubishi Tanabe Coughs Up $1.1 Billion Cash for This Parkinson's Biotech July 23, 2017 3 Biotechs Facing Big FDA Decisions in October September 26, 2017
